cmi_logo.png
[Latest] Global Tourism Market Size/Share Worth USD 12,313.5 Billion by 2032 at a 3.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
01 févr. 2024 11h30 HE | Custom Market Insights
Austin, TX, USA, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Tourism Market Size, Trends and Insights By Travel Purpose (Leisure Tourism,...
cmi_logo.png
[Latest] Global Tourism Source Market Size/Share Worth USD 986.5 Billion by 2032 at a 5.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
18 oct. 2023 17h30 HE | Custom Market Insights
Austin, TX, USA, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Tourism Source Market Size, Trends and Insights By Booking Channel (Websites,...
cmi_logo.png
[Latest] Global Corporate Travel Market Size/Share Worth USD 330.2 Billion by 2032 at a 13.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
06 juil. 2023 12h00 HE | Custom Market Insights
Austin, TX, USA, July 06, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Corporate Travel Market Size, Trends and Insights By Service (Transportation,...
Refocus Group Readie
Refocus Group Readies for Commercialization of VisAbility™ Micro Insert System; Expands Salesforce and Manufacturing Capacity
12 avr. 2018 09h05 HE | Refocus Group
DALLAS, April 12, 2018 (GLOBE NEWSWIRE) -- Refocus Group, a pioneer in vision-correcting technology, announced today that it has expanded its manufacturing and assembly capacity, and is...
Refocus Group Submit
Refocus Group Submits Final Module for Pre-Market Approval of the VisAbility™ Micro Insert System for Presbyopia
04 déc. 2017 09h05 HE | Refocus Group
DALLAS, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Refocus Group, a pioneer in vision-correcting technology, announced today that it has submitted its final module to the U.S. Food and Drug Administration...
Refocus Group Concludes 12-Month Follow-Up for Phase 3 Clinical Trial on the VisAbility(TM) Micro-Insert System for Presbyopia; Readies for Pre-Market Approval Submission
04 mai 2017 09h05 HE | Refocus Group
DALLAS, TX--(Marketwired - May 4, 2017) - Refocus Group, a pioneer in vision-correcting technology, announced today that it has successfully completed its 12-month follow-up on 360 patients in its...
Refocus Group Completes Phase 3 Clinical Trial on the VisAbility(TM) Micro-Insert System for Presbyopia; Raises Additional Funding
05 mai 2016 09h00 HE | Refocus Group, Inc.
DALLAS, TX--(Marketwired - May 5, 2016) - Refocus Group, a pioneer in vision-correcting technology, announced today that it has completed the enrollment of its Phase 3 clinical trial on the...
Kiterocket_Logo_RGB_300ppi.png
REC Group and Sunrun Sign Solar Panel Supply Agreement as the Company Accelerates U.S. Market Push
21 août 2014 11h00 HE | REC Group
OSLO, NORWAY and SAN FRANCISCO, CA--(Marketwired - Aug 21, 2014) - REC Group, a leading global provider of solar energy solutions, announced today the signing of a supply agreement with Sunrun, the...
Kiterocket_Logo_RGB_300ppi.png
REC Group Expands U.S. Product Offering With New 72-Cell Solar Panel for Large Commercial and Utility-Scale Markets
09 juil. 2014 13h00 HE | REC Group ASA
SAN FRANCISCO, CA--(Marketwired - Jul 9, 2014) - REC Group, a leading global provider of solar energy solutions, announced today that it will begin shipping its new high-quality, trade compliant...
MphasiS Wyde Releases Wynsure v5.0, End-to-End Platform for All Insurance Lines
30 avr. 2013 16h12 HE | MphasiS Wyde
MINNEAPOLIS, MN--(Marketwired - Apr 30, 2013) - MphasiS Wyde has released Wynsure v5.0, a new version of the end-to-end multi-line insurance system that provides more functionality to support group...